Wenli Xu
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 8
- Cancer, Hypoxia, and Metabolism 2
- Sesquiterpenes and Asteraceae Studies 2
-
- RNA modifications and cancer 5
- Protein Interaction Studies and Fluorescence Analysis 3
- Metabolomics and Mass Spectrometry Studies 2
-
- Drug Transport and Resistance Mechanisms 3
-
- Adipose Tissue and Metabolism 2
- Co-authors
- Liang‐Hu QuHui ZhouJianhua YangQiao-Juan HuangBin LiPenghui LinMin LiChang Liu
- Journals
- Proceedings of the National Academy of Sciences (1 paper)PLoS ONE (1 paper)The FASEB Journal (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wenli Xu
25 papers receiving 517 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 188
- Molecular Biology 389
- Cell Biology 54
- Parasitology 19
- Oncology 60
Countries citing papers authored by Wenli Xu
This map shows the geographic impact of Wenli Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenli Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenli Xu more than expected).
Fields of papers citing papers by Wenli Xu
This network shows the impact of papers produced by Wenli Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenli Xu. The network helps show where Wenli Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenli Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 9 | |
| 8 | 2022 | 11 | |
| 9 | 2022 | 26 | |
| 10 | 2022 | 23 | |
| 11 | 2021 | 24 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 18 | |
| 14 | 2021 | 20 | |
| 15 | 2021 | 4 | |
| 16 | 2019 | 28 | |
| 17 | 2019 | 21 | |
| 18 | 2019 | 67 | |
| 19 | 2017 | 95 | |
| 20 | 2017 | 71 |
About Wenli Xu
Wenli Xu is a scholar working on Cancer Research, Molecular Biology and Hepatology, having authored 27 papers that have together received 522 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (5 papers), Drug Transport and Resistance Mechanisms (3 papers), Protein Interaction Studies and Fluorescence Analysis (3 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Adipose Tissue and Metabolism (2 papers) and Sesquiterpenes and Asteraceae Studies (2 papers). The work is most often cited by research in Cancer Research (188 citations), Molecular Biology (389 citations) and Cell Biology (54 citations). Wenli Xu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Liang‐Hu Qu, Hui Zhou, Jianhua Yang, Qiao-Juan Huang, Bin Li, Penghui Lin, Min Li, Chang Liu, Wenbo Zhao and Jinhua Huang. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.